Cargando…
Genomic and Proteomic Biomarker Discovery in Neurological Disease
Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly developed to allow systematic analyses of human disease. Application of these technologies is becoming an increasingly effective approach for identifying the biological basis of genetically complex neur...
Autores principales: | Robeson, RiLee H., Siegel, Andrew M., Dunckley, Travis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688365/ https://www.ncbi.nlm.nih.gov/pubmed/19578496 |
Ejemplares similares
-
Proteomics Discovery of Disease Biomarkers
por: Ahram, Mamoun, et al.
Publicado: (2008) -
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation
por: Azorsa, David O, et al.
Publicado: (2010) -
Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders
por: Venugopal, Abhilash, et al.
Publicado: (2009) -
Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease
por: Wang, Shijie, et al.
Publicado: (2019) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)